Assessment of risk for developing coronary heart disease in asymptomatic individuals

Area of Science:

• Cardiology
• Preventive Medicine
• Clinical Risk Assessment

Background:

• Assessing coronary heart disease (CHD) risk in asymptomatic individuals presents a significant clinical challenge.
• Current risk assessment tools require refinement for comprehensive individual risk evaluation.
• Identifying subclinical disease and emerging risk factors remains an area of active research.

Purpose of the Study:

• To propose a pragmatic approach for assessing 10-year CHD risk in asymptomatic individuals.
• To highlight the importance of supplementing existing risk scores with additional clinical data.
• To suggest relevant diagnostic investigations for enhanced CHD risk evaluation.

Main Methods:

• Utilizing the Framingham risk score as a foundational tool for global 10-year CHD risk assessment.
• Recommending the incorporation of specific clinical factors: diabetes, metabolic syndrome, family history, and peripheral arterial disease.
• Suggesting additional investigations including ankle-brachial index measurement and functional capacity stress testing.

Main Results:

• The Framingham risk score serves as a practical basis for initial CHD risk stratification.
• Supplementation with additional clinical data refines individual risk assessment.
• Ankle-brachial index and functional stress tests are valuable additions to the diagnostic workup.

Conclusions:

• A comprehensive approach combining the Framingham risk score with specific clinical data and targeted investigations improves CHD risk assessment in asymptomatic individuals.
• The utility of emerging risk factors and routine subclinical disease detection requires further investigation.
• Clinicians should consider a multi-faceted strategy for evaluating 10-year CHD risk.